MDxHealth's ConfirmMDx Genes Identify Prostate Cancer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MDxHealth's ConfirmMDx Genes Identify Prostate Cancer Aggressiveness in Diagnostic Biopsies

IRVINE, Calif. and HERSTAL, Belgium, Oct. 10, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced positive data from an important study confirming the ability of the ConfirmMDx ® genes to identify prostate cancer (PCa) aggressiveness in diagnostic biopsies. The data, presented at the European Association of Urology, Section Urological Research (ESUR) meeting in Glasgow, UK (October 9-11, 2014), confirmed that the epigenetic profile of ConfirmMDx genes generated by the test is strongly correlated with established risk stratification metrics, such as Gleason Score (GS) and the NCCN (National Comprehensive Cancer Network) risk categories.

"These data demonstrate that ConfirmMDx for Prostate Cancer not only provides important diagnostic information to help guide the decision on repeat biopsy, but that the genes may also deliver significant prognostic value, potentially determining whether a man has an aggressive or non-aggressive form of prostate cancer," noted Sandra M. Gaston PhD, Director of Urological Research at New England Baptist Hospital and Director of the Molecular Biomarkers Research Laboratory in the Department of Pathology and Laboratory Medicine at Tufts Medical Center in Boston Massachusetts. "This study suggests that the epigenetic markers used in the ConfirmMDx test could have an expanded role in stratifying prostate biopsy patients by providing information that cannot be obtained from the histological examination of the tissue. The current ConfirmMDx test is highly sensitive for DNA hypermethylation of GSTP1, APC and RASSF1 in the tissue surrounding a prostate cancer. For men who have a histological diagnosis of "no cancer," a negative result with the current ConfirmMDx test predicts that a subsequent biopsy will also be negative, identifying the majority of men who may avoid repeat biopsy. In this study, we found that hypermethylation of these markers is more intense in the tissue surrounding high grade prostate cancer potentially providing additional insights into the clinical significance of a potential undetected prostate cancer on methylation-positive patients."

In this study, hypermethylation levels of the three ConfirmMDx genes ( GSTP1 , APC and RASSF1 ) were evaluated on biopsies from 102 men with various GS (ranging from 3+3 to 4+4) and NCCN (ranging from very low to high) risk profiles. All men had undergone a 12-core prostate biopsy under routine clinical practice resulting in their PCa diagnosis. No epigenetic aberrations for any of these three genes were found in 20 control patients, who had non-cancer histology in all of their 12-core biopsy specimens.

- For 46 men, the highest observed GS was 6, classifying these men as potential candidates for active surveillance; however, 17% (n=8) of them exhibited an epigenetic profile that is indicative of higher-grade disease.

-   Of the nine men with GS 4+3 or higher, 88% (n=8) had many epigenetic aberrations, in addition to 17 out of 27 (63%) of the men with GS 3+4.

-   When epigenetic profiling was compared to NCCN risk categories, similar results were obtained, identifying 79% (31 out of 39) of the men with intermediate or high NCCN risk profiles. Roughly one third of the patients in the very low and low risk categories showed similar epigenetic profiles.

In conclusion, epigenetic profiling using the ConfirmMDx test on individual biopsy cores could help identify patients harboring aggressive prostate cancer, aiding patient management.

"This study clearly demonstrates the power of ConfirmMDx to help guide management decisions for men who may harbor aggressive disease, and illustrates that our epigenetic genes clearly add prognostic information which correlates with the Gleason Score and NCCN risk categories," stated Dr. Jan Groen, CEO of MDxHealth.

About ConfirmMDx for Prostate Cancer

Over 975,000 American men are diagnosed with a negative prostate biopsy each year; however approximately 25-35% of those men receive false-negative results. Under the current standard of care, prostate biopsy procedures consisting of 10-12 needle biopsy cores only sample approximately 1% of a man's prostate.  This approach leaves men at risk of occult cancer, leading to a high rate of repeat biopsies, often on cancer-free men.  There is an unmet medical need for a clinically effective diagnostic test to address this dilemma.  ConfirmMDx for Prostate Cancer is able to detect an epigenetic field effect or 'halo' associated with the cancerization process at the DNA level. This "halo" around a cancer lesion can be present despite cells having a normal appearance under the microscope. Thus ConfirmMDx for Prostate Cancer aids urologists in identifying truly negative men who may forego an unnecessary repeat biopsy procedure. Performance of the proprietary ConfirmMDx genes and technology has been published in 45 studies on over 5,000 patients tested. The ConfirmMDx test has qualified for Medicare reimbursement as of November 3, 2014 and is also available to more than 152 million insured lives via private health insurance plans.

About MDxHealth

MDxHealth is a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment. The company's tests are based on proprietary gene methylation (epigenetics) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit mdxhealth.com and follow us on Twitter at twitter.com/mdxhealth .

For more information: 

Dr. Jan Groen, CEO  Mike Sinclair (media) 
MDxHealth Halsin Partners
US: +1 949 812 6979 UK: +44 20 7318 2955 
BE: +32 4 364 20 70 Cell: +44 7968 022075
info@mdxhealth.com msinclair@halsin.com

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation.  This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of MDxHealth in any jurisdiction. No securities of MDxHealth may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. securities laws.

NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx and PredictMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

To access the PDF version, click here http://hugin.info/137314/R/1861671/652848.pdf

HUG#1861671

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 71

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 89

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 110

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 77

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 226

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 112

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 115

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Feeding America Urges Collaboration to Combat Hunger Crisis

Updated Category News Views 148

Feeding America's Call to Action Against Hunger As food insecurity continues to rise, people across the nation who are struggling with hunger are urging us to unite and take meaningful steps to tackle this critical issue. Recent data indicates a troubling 6% increase in food insecurity over the past year, highlighting the immediate need for a collective response. Even...

Continue Reading
Aviat Networks Announces Participation in Key Investor Events

Updated Category News Views 136

Exciting Investor Conferences Ahead for Aviat Networks Aviat Networks, Inc. (NASDAQ: AVNW), a prominent player in the realm of wireless transport and access solutions, has recently unveiled its participation in some significant upcoming investor conferences. These conferences are an excellent opportunity for investors to engage with the company and learn more about its...

Continue Reading
Berkshire Hathaway Secures $1.9B with Major Samurai Bond Sale

Updated Category News Views 277

Berkshire Hathaway's Significant Samurai Bond Offering Berkshire Hathaway (NYSE: BRK) has successfully concluded a major bond offering, securing 281.8 billion yen, which is approximately $1.9 billion. This achievement marks the company's largest Samurai bond sale in five years, reflecting its strategic intent to deepen its investment footprint in the Japanese market. The...

Continue Reading
Top 10 Trading Mistakes to Avoid for Successful Investing

Updated Category News Views 150

The Costly Errors in Trading Many traders stumble not due to a lack of opportunities, but because they inadvertently make damaging decisions. It's crucial to recognize that the line between success and failure often lies in avoiding habits that negatively impact your trading account. In this article, we will delve into the 10 most detrimental trading mistakes....

Continue Reading
DEWALT POWERSHIFT™: Revolutionizing Electric Tools for Future Jobsites

Updated Category News Views 344

DEWALT POWERSHIFT™: A Leap Towards Sustainability DEWALT, a distinguished name in construction tools, has just introduced the DEWALT POWERSHIFT™ Cordless Equipment System, a groundbreaking series of tools designed to transform the future of jobsites. This innovative system significantly reduces environmental impact, boasting a remarkable capability to produce up to...

Continue Reading